Ephedra seizure
This article was originally published in The Tan Sheet
Executive Summary
More than 2 mil. capsules of Asia MedLabs' ephedra-containing Vitera-XT were seized from the firm's facility in Houston by U.S. Marshals, FDA announces Nov. 23. Vitera-XT, a "traditional Asian formulation," lists ephedrine alkaloids among its ingredients and carries claims such as "treat[s]...persistent flu, fevers and [may be used] for protein release." The complaint the ingredients and claims render the product an "unapproved new and misbranded drug." FDA's final rule banning the botanical was published in February (1"The Tan Sheet" Feb. 9, 2004, p. 10)...